Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Wood Microfluidics.
Andar A, Hasan MS, Srinivasan V, Al-Adhami M, Gutierrez E, Burgenson D, Ge X, Tolosa L, Kostov Y, Rao G. Andar A, et al. Anal Chem. 2019 Sep 3;91(17):11004-11012. doi: 10.1021/acs.analchem.9b01232. Epub 2019 Aug 13. Anal Chem. 2019. PMID: 31361950
Point-of-care production of therapeutic proteins of good-manufacturing-practice quality.
Adiga R, Al-Adhami M, Andar A, Borhani S, Brown S, Burgenson D, Cooper MA, Deldari S, Frey DD, Ge X, Guo H, Gurramkonda C, Jensen P, Kostov Y, LaCourse W, Liu Y, Moreira A, Mupparapu K, Peñalber-Johnstone C, Pilli M, Punshon-Smith B, Rao A, Rao G, Rauniyar P, Snovida S, Taurani K, Tilahun D, Tolosa L, Tolosa M, Tran K, Vattem K, Veeraraghavan S, Wagner B, Wilhide J, Wood DW, Zuber A. Adiga R, et al. Nat Biomed Eng. 2018 Sep;2(9):675-686. doi: 10.1038/s41551-018-0259-1. Epub 2018 Jul 9. Nat Biomed Eng. 2018. PMID: 31015674
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study.
Patriquin CJ, Bogdanovic A, Griffin M, Kelly RJ, Maciejewski JP, Mulherin B, Peffault de Latour R, Röth A, Selvaratnam V, Szer J, Al-Adhami M, Horneff R, Tan L, Yeh M, Panse J. Patriquin CJ, et al. Among authors: al adhami m. Adv Ther. 2024 May;41(5):2050-2069. doi: 10.1007/s12325-024-02827-8. Epub 2024 Apr 4. Adv Ther. 2024. PMID: 38573482 Free PMC article.
Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison.
Wong R, Fishman J, Wilson K, Yeh M, Al-Adhami M, Zion A, Yee CW, Huynh L, Duh MS. Wong R, et al. Among authors: al adhami m. Adv Ther. 2023 Dec;40(12):5591-5595. doi: 10.1007/s12325-023-02640-9. Epub 2023 Oct 4. Adv Ther. 2023. PMID: 37789229 Free PMC article. No abstract available.
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
Wong RSM, Navarro-Cabrera JR, Comia NS, Goh YT, Idrobo H, Kongkabpan D, Gómez-Almaguer D, Al-Adhami M, Ajayi T, Alvarenga P, Savage J, Deschatelets P, Francois C, Grossi F, Dumagay T. Wong RSM, et al. Among authors: al adhami m. Blood Adv. 2023 Jun 13;7(11):2468-2478. doi: 10.1182/bloodadvances.2022009129. Blood Adv. 2023. PMID: 36848639 Free PMC article. Clinical Trial.
34 results